Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Neuroprotective effect of a novel Chinese herbal decoction on cultured neurons and cerebral ischemic rats.

Ip FC, Zhao YM, Chan KW, Cheng EY, Tong EP, Chandrashekar O, Fu GM, Zhao ZZ, Ip NY.

BMC Complement Altern Med. 2016 Nov 4;16(1):437.

2.

Aloe-emodin suppresses esophageal cancer cell TE1 proliferation by inhibiting AKT and ERK phosphorylation.

Chang X, Zhao J, Tian F, Jiang Y, Lu J, Ma J, Zhang X, Jin G, Huang Y, Dong Z, Liu K, Dong Z.

Oncol Lett. 2016 Sep;12(3):2232-2238. Epub 2016 Jul 25.

3.
4.

Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells.

Mitton B, Chae HD, Hsu K, Dutta R, Aldana-Masangkay G, Ferrari R, Davis K, Tiu BC, Kaul A, Lacayo N, Dahl G, Xie F, Li BX, Breese MR, Landaw EM, Nolan G, Pellegrini M, Romanov S, Xiao X, Sakamoto KM.

Leukemia. 2016 Dec;30(12):2302-2311. doi: 10.1038/leu.2016.139. Epub 2016 May 23.

5.

Nuclear TRAF3 is a negative regulator of CREB in B cells.

Mambetsariev N, Lin WW, Stunz LL, Hanson BM, Hildebrand JM, Bishop GA.

Proc Natl Acad Sci U S A. 2016 Jan 26;113(4):1032-7. doi: 10.1073/pnas.1514586113. Epub 2016 Jan 11.

6.

Bay 61-3606 Sensitizes TRAIL-Induced Apoptosis by Downregulating Mcl-1 in Breast Cancer Cells.

Kim SY, Park SE, Shim SM, Park S, Kim KK, Jeong SY, Choi EK, Hwang JJ, Jin DH, Chung CD, Kim I.

PLoS One. 2015 Dec 31;10(12):e0146073. doi: 10.1371/journal.pone.0146073. eCollection 2015.

7.

Leishmania donovani Exploits Myeloid Cell Leukemia 1 (MCL-1) Protein to Prevent Mitochondria-dependent Host Cell Apoptosis.

Giri J, Srivastav S, Basu M, Palit S, Gupta P, Ukil A.

J Biol Chem. 2016 Feb 12;291(7):3496-507. doi: 10.1074/jbc.M115.672873. Epub 2015 Dec 15.

8.
9.

Transcriptomic Analysis and Meta-Analysis of Human Granulosa and Cumulus Cells.

Burnik Papler T, Vrtacnik Bokal E, Maver A, Kopitar AN, Lovrečić L.

PLoS One. 2015 Aug 27;10(8):e0136473. doi: 10.1371/journal.pone.0136473. eCollection 2015.

10.

Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells.

Fedorenko IV, Abel EV, Koomen JM, Fang B, Wood ER, Chen YA, Fisher KJ, Iyengar S, Dahlman KB, Wargo JA, Flaherty KT, Sosman JA, Sondak VK, Messina JL, Gibney GT, Smalley KS.

Oncogene. 2016 Mar 10;35(10):1225-35. doi: 10.1038/onc.2015.188. Epub 2015 Jun 15.

11.

Outlook on PI3K/AKT/mTOR inhibition in acute leukemia.

Fransecky L, Mochmann LH, Baldus CD.

Mol Cell Ther. 2015 Mar 20;3:2. doi: 10.1186/s40591-015-0040-8. eCollection 2015.

12.

Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF.

Fischer R, Maier O.

Oxid Med Cell Longev. 2015;2015:610813. doi: 10.1155/2015/610813. Epub 2015 Mar 5. Review.

13.

FLT3-ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia.

Nogami A, Oshikawa G, Okada K, Fukutake S, Umezawa Y, Nagao T, Kurosu T, Miura O.

Oncotarget. 2015 Apr 20;6(11):9189-205.

14.

PI3K-independent mTOR activation promotes lapatinib resistance and IAP expression that can be effectively reversed by mTOR and Hsp90 inhibition.

Brady SW, Zhang J, Tsai MH, Yu D.

Cancer Biol Ther. 2015;16(3):402-11. doi: 10.1080/15384047.2014.1002693.

15.

Regulation of Mcl-1 expression in context to bone marrow stromal microenvironment in chronic lymphocytic leukemia.

Balakrishnan K, Burger JA, Fu M, Doifode T, Wierda WG, Gandhi V.

Neoplasia. 2014 Dec;16(12):1036-46. doi: 10.1016/j.neo.2014.10.002.

16.

Proteinase-activated receptor 2 (PAR2) decreases apoptosis in colonic epithelial cells.

Iablokov V, Hirota CL, Peplowski MA, Ramachandran R, Mihara K, Hollenberg MD, MacNaughton WK.

J Biol Chem. 2014 Dec 5;289(49):34366-77. doi: 10.1074/jbc.M114.610485. Epub 2014 Oct 20.

17.

The androgen receptor mediates antiapoptotic function in myometrial cells.

Li H, Li Y, Morin D, Plymate S, Lye S, Dong X.

Cell Death Dis. 2014 Jul 17;5:e1338. doi: 10.1038/cddis.2014.303.

18.

Rational combination of dual PI3K/mTOR blockade and Bcl-2/-xL inhibition in AML.

Vachhani P, Bose P, Rahmani M, Grant S.

Physiol Genomics. 2014 Jul 1;46(13):448-56. doi: 10.1152/physiolgenomics.00173.2013. Epub 2014 May 13. Review.

19.

The Bcl-2/xL inhibitor ABT-263 increases the stability of Mcl-1 mRNA and protein in hepatocellular carcinoma cells.

Wang B, Ni Z, Dai X, Qin L, Li X, Xu L, Lian J, He F.

Mol Cancer. 2014 Apr 30;13:98. doi: 10.1186/1476-4598-13-98.

20.

SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells.

Bu Q, Cui L, Li J, Du X, Zou W, Ding K, Pan J.

Cancer Biol Ther. 2014 Jul;15(7):951-62. doi: 10.4161/cbt.28931. Epub 2014 Apr 23.

Supplemental Content

Support Center